Table I.
Clinicopathological variables and FRMD4A expression in OSCC.
Characteristics | Patients | FRMD4A
|
χ2 | P-value | |
---|---|---|---|---|---|
Overexpression | % | ||||
Gender | |||||
Male | 40 | 27 | 67.5 | 0.412 | 0.521 |
Female | 38 | 23 | 60.5 | ||
Age | |||||
<55 | 36 | 21 | 58.3 | 0.967 | 0.325 |
≥55 | 42 | 29 | 69.0 | ||
Grading | |||||
I | 20 | 11 | 55.0 | 1.140 | 0.565 |
II | 47 | 31 | 66.0 | ||
III | 11 | 8 | 72.7 | ||
Lymph node metastasis | |||||
Yes | 35 | 28 | 80.0 | 6.973 | 0.008 |
No | 43 | 22 | 51.2 | ||
Clinical stage | |||||
I+II | 31 | 14 | 45.2 | 8.021 | 0.005 |
III+IV | 47 | 36 | 76.6 |
OSCC, oral squamous cell carcinoma; FRMD4A, FERM domain containing 4A.